BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ical.marudot.com//iCal Event Maker
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:Asia/Singapore
LAST-MODIFIED:20240422T053450Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Asia/Singapore
X-LIC-LOCATION:Asia/Singapore
BEGIN:STANDARD
TZNAME:+08
TZOFFSETFROM:+0800
TZOFFSETTO:+0800
DTSTART:19700101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTAMP:20251017T081626Z
UID:1760084014508-90376@ical.marudot.com
DTSTART;TZID=Asia/Singapore:20251114T170000
DTEND;TZID=Asia/Singapore:20251114T190000
SUMMARY:Diabetes Treatment & End Organ Protection Webinar
DESCRIPTION:This e-learning course equips clinicians to integrate end organ protection into diabetes care. It highlights the central role of SGLT2 inhibitors and GLP-1 agonists\, whose benefits extend beyond glucose lowering to improving long-term cardiovascular and renal outcomes. \n\nTopics covered     \nCase Example​ \nCardiovascular Risk in Diabetes​ \nAntidiabetic Agents with Neutral Cardiovascular (CV) Benefits​ \nAntidiabetic Agents with Benefits Beyond Glycemic Control: ​ \nAntidiabetic Agents with Proven CV Benefits​ \nSodium-Glucose Cotransporter-2 inhibitors (SGLT2i)​ \nGlucagon-like Peptide-1 Receptor Agonists (GLP1-RA)​ \nDiabetic Therapies with Renal Protection​ \nObesity and Cardiovascular Disease​ \nObesity and Heart Failure with Preserved Ejection Fraction (HFpEF)​ \nRecommendations of the 2023 European Society of Cardiology (ESC) Guidelines \n\nVisit: https://education.mims.com/
LOCATION:Webinar held on the MIMS Education platform - https://education.mims.com/
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Diabetes Treatment & End Organ Protection Webinar
TRIGGER:-P1D
END:VALARM
BEGIN:VALARM
ACTION:DISPLAY
DESCRIPTION:Diabetes Treatment & End Organ Protection Webinar
TRIGGER:-PT30M
END:VALARM
END:VEVENT
END:VCALENDAR